Letter from the President
 | Despite the billions of dollars spent annually to cure this
disease, Alzheimer’s claims over 1 in 10 people over the age of 65 and
represents a growing threat in the backdrop of an aging population. In
fact, it is expected to claim over half of the people over 85 in coming
years. Coincidentally, the past twenty years have seen substantial
advances in the Neurosciences and allied fields. These major
contributions, from the discovery of human stem cells in areas affected
by Alzheimer’s to the sequencing of the Human Genome, have given rise
to new tools, which are ripe for applications to the field of
Alzheimer’s. It is high time to introduce researchers responsible for
these findings to the Alzheimer’s community. In this spirit, we have
convened some of the world’s most daring and innovative researchers to
share their insights in the form of an international summit with
Alzheimer’s as a leitmotiv, held in the Principality of Monaco in
February 2010.
I am grateful to Prince Albert II of Monaco, Madame Catherine
Pastor of AMPA and First Lady Bernadette Chirac for the invitation to
create this event and for recognizing the need to develop completely
novel strategies against Alzheimer’s growing menace. Our meeting will be an interactive, interdisciplinary and international event
at the forefront of academic, governmental and industrial research with
speakers representing a confluence of fields including Stem Cell
Research, Neurobiology, Artificial Intelligence, and Telemedicine. |
| I look forward to welcoming you next February, for a truly world-class and unforgettable event. | |
| Sincerely, | |
 |
| Dr. Philip Low Founder, Chairman & CEO, NeuroVigil, Inc. Adjunct Professor, Stanford School of Medicine Visiting Professor, Massachusetts Institute of Technology |